158 related articles for article (PubMed ID: 30521173)
1. Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 - 100 ng / mL.
Iwamoto H; Izumi K; Kadono Y; Mizokami A
Int Braz J Urol; 2019; 45(1):61-67. PubMed ID: 30521173
[TBL] [Abstract][Full Text] [Related]
2. The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels.
Izumi K; Ikeda H; Maolake A; Machioka K; Nohara T; Narimoto K; Ueno S; Kadono Y; Kitagawa Y; Konaka H; Mizokami A; Namiki M
Prostate; 2015 Jul; 75(10):1034-42. PubMed ID: 25753899
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level.
Izumi K; Lin WJ; Miyamoto H; Huang CK; Maolake A; Kitagawa Y; Kadono Y; Konaka H; Mizokami A; Namiki M
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1413-9. PubMed ID: 24747988
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic characteristics and prognosis of early onset prostate cancer].
Wang Y; Du SJ; Zhang JX; He HY
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):373-377. PubMed ID: 28591982
[No Abstract] [Full Text] [Related]
5. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract][Full Text] [Related]
6. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
[TBL] [Abstract][Full Text] [Related]
7. The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
Eminaga O; Hinkelammert R; Titze U; Abbas M; Eltze E; Bettendorf O; Semjonow A
Urol Oncol; 2014 Jan; 32(1):32.e17-25. PubMed ID: 23434425
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL.
Chang CC; Lee YC; Tsai HW; Yii SC; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2015; 16(13):5261-4. PubMed ID: 26225663
[TBL] [Abstract][Full Text] [Related]
9. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
10. Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.
Alexander AS; Mydin A; Jones SO; Christie J; Lim JT; Truong PT; Ludgate CM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e713-9. PubMed ID: 21277102
[TBL] [Abstract][Full Text] [Related]
11. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.
Eminaga O; Hinkelammert R; Abbas M; Wötzel F; Eltze E; Bettendorf O; Boegemann M; Semjonow A
Urology; 2015 Oct; 86(4):798-804. PubMed ID: 26255036
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
[TBL] [Abstract][Full Text] [Related]
14. Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.
Naik M; Reddy CA; Stephans KL; Ciezki JP; Garcia J; Grivas P; Stephenson AJ; Klein EA; Tendulkar RD
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):617-23. PubMed ID: 27681757
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.
Santok GD; Abdel Raheem A; Kim LH; Chang K; Lum TG; Chung BH; Choi YD; Rha KH
Investig Clin Urol; 2017 Mar; 58(2):90-97. PubMed ID: 28261677
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
[TBL] [Abstract][Full Text] [Related]
17. Reduced cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer: A population-based retrospective cohort study.
Song P; Yang B; Peng Z; Zhou J; Ren Z; Fang K; Yang L; Wang L; Dong Q
Int J Surg; 2020 Apr; 76():64-68. PubMed ID: 32109649
[TBL] [Abstract][Full Text] [Related]
18. Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigen.
Falchook AD; Martin NE; Basak R; Smith AB; Milowsky MI; Chen RC
Urol Oncol; 2016 Mar; 34(3):119.e19-26. PubMed ID: 26526383
[TBL] [Abstract][Full Text] [Related]
19. Four prognostic indices in advanced prostate cancer patients, under palliative androgen deprivation treatment.
Bantis A; Zissimopoulos A; Kalaitzis C; Giannakopoulos S; Sountoulides P; Parmenopoulou V; Agelonidou E; Touloupidis S
Hell J Nucl Med; 2008; 11(1):21-5. PubMed ID: 18392222
[TBL] [Abstract][Full Text] [Related]
20. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
